Literature DB >> 11535145

The importance of dedifferentiation in recurrent acinic cell carcinoma.

C I Timon1, I Dardick.   

Abstract

The biological activity of acinic cell carcinoma is uncertain. Histological dedifferentiation is one possible reason for recurrent disease, and this study was undertaken to assess its importance in acinic cell carcinoma. The initial and recurrent specimens from five patients with acinic cell carcinoma were assessed histologically and using flow cytometry, AgNOR estimation and morphometric analysis for evidence of dedifferentiation. No objective evidence of a change in biological aggressiveness in recurrent acinic cell carcinoma was identified. In this limited series of a rare salivary gland tumour, it would appear that factors other than dedifferentiation, such as close/involved margins, histological type and stage have a more meaningful effect on the likelihood of recurrence and prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535145     DOI: 10.1258/0022215011908711

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  Prognostic relevance of cell proliferation in major salivary gland carcinomas.

Authors:  M Vacchi Suzzi; A Alessi; C Bertarelli; A Cancellieri; L Procaccio; D Dall'olio; P Laudadio
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 2.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03

3.  High-Grade Transformation (Dedifferentiation) of Acinic Cell Carcinoma of the Parotid Gland: Report of an Unusual Variant.

Authors:  Sarah S Al-Otaibi; Faiza Alotaibi; Yaseer Al Zaher; Nabil Al Zaher; M A Dababo
Journal:  Case Rep Otolaryngol       Date:  2017-05-14

4.  A Rare Case of Brain Metastasis from Dedifferentiated Acinic Cell Carcinoma of the Parotid Gland and Review of the Literature.

Authors:  Elham Mirzaian; Shafighe Asgari Karchekani; Ashkan Abdoli
Journal:  Iran J Pathol       Date:  2021-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.